We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smartphone-Based ELISA Developed for Blood Antigens

By LabMedica International staff writers
Posted on 14 Aug 2017
Print article
Image: A prototype of the D4 assay (Photo courtesy of Daniel Joh, Duke University).
Image: A prototype of the D4 assay (Photo courtesy of Daniel Joh, Duke University).
A novel high speed, lab-on-a-chip ELISA test for antigens in blood samples depends on a unique nonstick polymer coating that eliminates the need for multiple incubation and washing steps.

Investigators at Duke University (Durham, NC, USA) used an ink-jet printer to spray an array of antibodies onto glass slides treated with a unique nonstick polymer brush coating. The coating functioned like Teflon to prevent non-target proteins from attaching to the surface of the slide and causing high levels of background "noise".

The investigators "D4 assay" utilized a matched pair of antibodies to detect and capture a target protein in a blood sample. The fixed array on the slide comprised immobilized capture antibodies and soluble detection antibodies, which were labeled with a fluorescent marker to allow quantitation of the antigen (if present). Placing a drop of blood on the slide caused the detection antibodies to dissolve, separate from the array, and bind to target proteins in the sample. The fluorescing antibody-antigen pairs then attached to the capture antibodies on the slide. A buffer solution was used to remove any proteins not bound to the slide's nonstick polymer brush coating. Assay results were read with a smartphone based detector system.

As a proof-of-concept for the accuracy of the assay, the investigators measured the levels of leptin in patients' serum with the D4 assay and compared them to those obtained with a clinical ELISA platform. This study found that the results from the D4 assay were on par with those from the ELISA test.

"The real significance of the assay is the polymer brush coating," said senior author Dr. Ashutosh Chilkoti, professor of biomedical engineering at Duke University. "The polymer brush allowed us to store all of the tools we need on the chip while maintaining a simple design."

The D4 system was discussed in detail in the August 7, 2017, online edition of the Proceedings of the [U.S.] National Academy of Sciences.

Related Links:
Duke University

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The breakthrough could result in a higher success rate using a simple oral swab test before IVF (Photo courtesy of Shutterstock)

POC Oral Swab Test to Increase Chances of Pregnancy in IVF

Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.